Cancer's Hidden Code: How AI Reveals Tumors' Molecular Secrets

Indian scientists have developed a groundbreaking AI framework that could transform cancer treatment. The system called OncoMark reads cancer's molecular personality rather than just tumor size. It analyzes hidden biological programs that explain how healthy cells turn malignant and resist treatment. This breakthrough enables truly personalized therapy by identifying which cancer hallmarks are active in individual patients.

Key Points: Indian Scientists Develop AI Framework for Personalized Cancer Therapy

  • AI framework analyzes 3.1 million single cells across 14 cancer types
  • OncoMark achieved over 99% accuracy in predicting cancer behavior
  • Framework reveals active hallmarks driving tumor growth and resistance
  • Helps identify aggressive cancers missed by traditional staging systems
  • Enables personalized drug targeting based on molecular profiles
2 min read

Indian scientists tap AI for personalised cancer therapy

S N Bose scientists create OncoMark AI that reads cancer's molecular personality with 99% accuracy, enabling personalized treatment approaches beyond traditional staging.

"Cancer is not just a disease of growing tumours — it is powered by a set of hidden biological programmes called the hallmarks of cancer - Ministry of Science and Technology"

New Delhi, Nov 26

Scientists at the S N Bose National Centre for Basic Sciences introduced an artificial intelligence (AI) framework that could change how we understand and treat cancer, and also pave the way for personalised therapies, the Ministry of Science and Technology said on Wednesday.

The framework, developed in collaboration with Ashoka University, gives a new lens to look at cancer -- not by its size or spread alone, but by its molecular personality.

"Cancer is not just a disease of growing tumours -- it is powered by a set of hidden biological programmes called the hallmarks of cancer. These hallmarks explain how healthy cells turn malignant: how they spread, evade the immune system, and resist treatment," the Ministry said.

While for decades, doctors have relied on staging systems like TNM, which describe the size and spread of tumours, they often miss the deeper molecular story. For example, why two patients with the "same" cancer stage can have very different outcomes.

The new AI framework titled OncoMark can read the molecular "mind" of cancer and predict its behaviour, the Ministry said.

The team at SN Bose, led by Dr. Shubhasis Haldar and Dr. Debayan Gupta, used OncoMark to analyse 3.1 million single cells across 14 cancer types.

S N Bose is an autonomous institute of the Department of Science and Technology (DST).

The research team created synthetic "pseudo-biopsies" that represent hallmark-driven tumour states.

This huge dataset allowed the AI to learn how hallmarks like metastasis, immune evasion, and genomic instability work together to fuel tumour growth and therapy resistance.

"OncoMark achieved over 99 per cent accuracy in internal testing and remained above 96 per cent across five independent cohorts. It was validated on 20,000 real-world patient samples from eight major datasets, showing broad applicability. For the first time, scientists could actually visualise how hallmark activity rises with advancing cancer stage," the Ministry said.

The new framework, published in the Nature journal Communications Biology, reveals which hallmarks are active in a patient's tumour. This can direct doctors toward drugs that directly target those processes.

It can also help identify aggressive cancers that might look less harmful under standard staging, supporting earlier intervention, the Ministry said.

- IANS

Share this article:

Reader Comments

R
Rohit P
Amazing work by SN Bose Centre! But I hope this technology becomes affordable and accessible to common people in government hospitals, not just private ones. Healthcare should be for all, not just the wealthy.
D
David E
As someone working in healthcare tech, this is groundbreaking. The 96%+ accuracy across independent cohorts is impressive. India is really stepping up in medical AI research. Well done team!
A
Ananya R
Finally moving beyond just tumor size! The molecular approach makes so much more sense. Hope this reaches cancer patients soon. 🙏
S
Sarah B
The collaboration between SN Bose and Ashoka University shows how academia-industry partnerships can drive innovation. More such initiatives needed across India's research ecosystem.
V
Vikram M
Great achievement, but let's not forget the importance of early detection and prevention. While AI helps treatment, we need better awareness about cancer screening in rural India too.

We welcome thoughtful discussions from our readers. Please keep comments respectful and on-topic.

Leave a Comment

Minimum 50 characters 0/50